Azilsartan as an antihypertensive treatment in Japanese children under 6 years old: A phase 3 open-label long-term study
Pediatr Int. 2025 Jan-Dec;67(1):e70284. doi: 10.1111/ped.70284. ABSTRACT BACKGROUND: Pediatric hypertension presents unique challenges in its management and treatment. A previous study demonstrated the safety and …